Ceftriaxone-resistant, multidrug-resistant Neisseria gonorrhoeae with a novel mosaic penA-237.001 gene, France, June 2022

We report a ceftriaxone-resistant, multidrug-resistant urogenital gonorrhoea case in a heterosexual woman in France, June 2022. The woman was successfully treated with azithromycin 2?g. She had unprotected sex with her regular partner, who developed urethritis following travel to Vietnam and Switzerland. Whole genome sequencing of the gonococcal isolate (F92) identified MLST ST1901, NG-STAR CC-199, and the novel mosaic penA-237.001, which caused ceftriaxone resistance. penA-237.001 is 98.7% identical to penA-60.001, reported in various ceftriaxone-resistant strains, including the internationally spreading FC428 clone.

Auteur(s) : Berçot Béatrice, Caméléna François, Mérimèche Manel, Jacobsson Susanne, Sbaa Ghalia, Mainardis Mary, Valin Cyrille, Molina Jean-Michel, Bébéar Cécile, Chazelle Emilie, Lot Florence, Golparian Daniel, Unemo Magnus

Année de publication : 2022

Pages : 2200899

En relation avec

Nos dernières actualités

actualité

« Protéger la population des risques de l’alcool ». Le dossier de La Santé...

actualité

Appel à candidature pour compléter le Comité national des infections...

actualité

Semaine de la santé sexuelle 2026 : le dépistage et la prévention restent...